KMDS
E-submission
Search
- Page Path
- HOME > Search
Review Article
- Long-Term Outcomes of Genetic Parkinson’s Disease
- Jan O. Aasly
- J Mov Disord. 2020;13(2):81-96. Published online May 29, 2020
- DOI: https://doi.org/10.14802/jmd.19080
- 13,653 View
- 423 Download
- 20 Web of Science
- 21 Crossref
-
Abstract
PDF - Parkinson’s disease (PD) is a progressive neurodegenerative disorder that affects 1–2% of people by the age of 70 years. Age is the most important risk factor, and most cases are sporadic without any known environmental or genetic causes. Since the late 1990s, mutations in the genes SNCA, PRKN, LRRK2, PINK1, DJ-1, VPS35, and GBA have been shown to be important risk factors for PD. In addition, common variants with small effect sizes are now recognized to modulate the risk for PD. Most studies in genetic PD have focused on finding new genes, but few have studied the long-term outcome of patients with the specific genetic PD forms. Patients with known genetic PD have now been followed for more than 20 years, and we see that they may have distinct and different prognoses. New therapeutic possibilities are emerging based on the genetic cause underlying the disease. Future medication may be based on the pathophysiology individualized to the patient’s genetic background. The challenge is to find the biological consequences of different genetic variants. In this review, the clinical patterns and long-term prognoses of the most common genetic PD variants are presented.
-
Citations
Citations to this article as recorded by
- Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics
Yoonjeong Cha, Mohamedi N. Kagalwala, Jermaine Ross
Pharmaceuticals.2024; 17(2): 158. CrossRef - The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson’s Disease: a New Genetic State of the Art
Júlio César Claudino dos Santos, Gabriela Braga Cabrera Mano, André Rodrigues da Cunha Barreto-Vianna, Tulia Fernanda Meira Garcia, Aline Vieira de Vasconcelos, Caio Sérgio Gomes Sá, Sarah Lopes de Souza Santana, Ana Gabriela Ponte Farias, Beatriz Seimaru
Molecular Neurobiology.2024;[Epub] CrossRef - Early Onset Parkinson’s Disease and It’s Genetic Consequences
Hatice ÖMERCİKOĞLU ÖZDEN, Dilek GÜNAL
OSMANGAZİ JOURNAL OF MEDICINE.2024;[Epub] CrossRef - Genotype–phenotype correlation in PRKN-associated Parkinson’s disease
Poornima Jayadev Menon, Sara Sambin, Baptiste Criniere-Boizet, Thomas Courtin, Christelle Tesson, Fanny Casse, Melanie Ferrien, Louise-Laure Mariani, Stephanie Carvalho, Francois-Xavier Lejeune, Sana Rebbah, Gaspard Martet, Marion Houot, Aymeric Lanore, G
npj Parkinson's Disease.2024;[Epub] CrossRef - Factors Influencing Patient Disclosure of Parkinson's Disease Genetic Testing Results to Relatives
Jeanine Schulze, Jasmine Kaur Dhaliwal, Mandy Miller, Emily Quinn, Leah Wetherill, Lola Cook
Movement Disorders Clinical Practice.2024;[Epub] CrossRef - Staging Parkinson’s Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
Diego Santos-García, Teresa de Deus Fonticoba, Carlos Cores Bartolomé, Maria J. Feal Painceiras, Maria Cristina Íñiguez-Alvarado, Iago García Díaz, Silvia Jesús, Maria Teresa Buongiorno, Lluís Planellas, Marina Cosgaya, Juan García Caldentey, Nuria Caball
Journal of Parkinson's Disease.2023; 13(3): 379. CrossRef - To lump or to split? Deep brain stimulation may improve non-motor symptoms in certain Parkinson's disease subtypes
Neepa Patel
Parkinsonism & Related Disorders.2023; 109: 105369. CrossRef - Emerging Roles of Signal Transduction Pathways in Neurodegenerative Diseases. Hunting New Possible Therapeutic Molecular Targets
Vincenza Rita Lo Vasco
OBM Geriatrics.2023; 07(02): 1. CrossRef - Genome- and Exome-Wide Association Studies Revealed Candidate Genes Associated with DaTscan Imaging Features
Arash Yaghoobi, Homa Seyedmirzaei, Moein Ala, Cristine Alves da Costa
Parkinson's Disease.2023; 2023: 1. CrossRef - Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
Jamir Pitton Rissardo, Ana Letícia Fornari Caprara
Brain Sciences.2023; 13(10): 1471. CrossRef - Applicability of clinical genetic testing for deep brain stimulation treatment in monogenic Parkinson’s disease and monogenic dystonia: a multidisciplinary team perspective
Valentino Rački, Mario Hero, Eliša Papić, Gloria Rožmarić, Nada Starčević Čizmarević, Darko Chudy, Borut Peterlin, Vladimira Vuletić
Frontiers in Neuroscience.2023;[Epub] CrossRef - PTEN-Induced Putative Kinase 1 Dysfunction Accelerates Synucleinopathy
Tinh Thi Nguyen, Yun Joong Kim, Thuy Thi Lai, Phuong Thi Nguyen, Young Ho Koh, Linh Thi Nhat Nguyen, Hyeo-il Ma, Young Eun Kim
Journal of Parkinson's Disease.2022; 12(4): 1201. CrossRef - Oncogenic Pathways in Neurodegenerative Diseases
Luis Varela, Maria E. R. Garcia-Rendueles
International Journal of Molecular Sciences.2022; 23(6): 3223. CrossRef - Genetic Determinants of Survival in Parkinson's Disease in the Asian Population
Chunyu Li, Yanbing Hou, Ruwei Ou, Xiaojing Gu, Yongping Chen, Lingyu Zhang, Kuncheng Liu, Junyu Lin, Bei Cao, Qianqian Wei, Xueping Chen, Wei Song, Bi Zhao, Ying Wu, Yiyuan Cui, Huifang Shang
Movement Disorders.2022; 37(8): 1624. CrossRef - Obituary for Jan O. Aasly (1950–2022)
Matthew J. Farrer
Movement Disorders.2022; 37(9): 1783. CrossRef - Genetics in parkinson’s disease: From better disease understanding to machine learning based precision medicine
Mohamed Aborageh, Peter Krawitz, Holger Fröhlich
Frontiers in Molecular Medicine.2022;[Epub] CrossRef - Recent developments in nucleic acid-based therapies for Parkinson’s disease: Current status, clinical potential, and future strategies
Shivam Kumar Pandey, Rakesh Kumar Singh
Frontiers in Pharmacology.2022;[Epub] CrossRef - Genetic stratification of motor and QoL outcomes in Parkinson's disease in the EARLYSTIM study
Daniel Weiss, Zied Landoulsi, Patrick May, Manu Sharma, Michael Schüpbach, Hana You, Jean Christophe Corvol, Steffen Paschen, Ann-Kristin Helmers, Michael Barbe, Gereon Fink, Andrea A. Kühn, Christine Brefel Courbon, Lars Wojtecki, Philippe Damier, Valeri
Parkinsonism & Related Disorders.2022; 103: 169. CrossRef - Inflammatory Diseases Among Norwegian LRRK2 Mutation Carriers. A 15-Years Follow-Up of a Cohort
Jan O. Aasly
Frontiers in Neuroscience.2021;[Epub] CrossRef - Increased Mortality in Young-Onset Parkinson’s Disease
Eldbjørg Hustad, Tor Åge Myklebust, Sasha Gulati, Jan O. Aasly
Journal of Movement Disorders.2021; 14(3): 214. CrossRef - Contributing Factors and Evolution of Impulse Control Disorder in the Luxembourg Parkinson Cohort
Sylvia Binck, Claire Pauly, Michel Vaillant, Geraldine Hipp, Manon Gantenbein, Rejko Krueger, Nico J Diederich
Frontiers in Neurology.2020;[Epub] CrossRef
- Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics
First
Prev
